Michael P Notarianni, MD | |
1005 N Glebe Rd, #750, Arlington, VA 22201-5718 | |
(703) 524-7202 | |
(703) 516-4501 |
Full Name | Michael P Notarianni |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 31 Years |
Location | 1005 N Glebe Rd, Arlington, Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1487658357 | NPI | - | NPPES |
060068398 | Other | DC | RAILROAD MEDICARE DC # |
060068399 | Other | VA | RAILROAD MEDICARE VA # |
386811700 | Medicaid | MD | |
034038900 | Medicaid | DC | |
1487658357 | Medicaid | VA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 0101051518 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Virginia Hospital Center | Arlington, VA | Hospital |
Inova Alexandria Hospital | Alexandria, VA | Hospital |
Inova Fairfax Hospital | Falls church, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Inova Health Care Services | 2466351093 | 1725 |
Inova Health Care Services | 2466351093 | 1725 |
News Archive
Scientists have engineered tissue grafts that, in pigs, regenerated both bone and cartilage in the temporomandibular joint (TMJ), a part of the jaw that can cause debilitating pain and disability when damaged.
Over the course of 2017, positive trends in insurance coverage and healthcare access from the Affordable Care Act reversed, particularly for low-income residents of states that did not expand Medicaid.
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Raptor Pharmaceutical Corp., announced that it has entered into an exclusive agreement with Uni Pharma Co., Ltd. to commercialize Convivia™, Raptor's proprietary oral formulation of 4-methylpyrazole, in Taiwan.
Rutgers researchers studying COVID-19 have created a new way to deliver DNA molecules into skin cells, using a suction technique similar to the ancient healing practice of cupping.
› Verified 6 days ago
Entity Name | Inova Health Care Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20040102000644 |
News Archive
Scientists have engineered tissue grafts that, in pigs, regenerated both bone and cartilage in the temporomandibular joint (TMJ), a part of the jaw that can cause debilitating pain and disability when damaged.
Over the course of 2017, positive trends in insurance coverage and healthcare access from the Affordable Care Act reversed, particularly for low-income residents of states that did not expand Medicaid.
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Raptor Pharmaceutical Corp., announced that it has entered into an exclusive agreement with Uni Pharma Co., Ltd. to commercialize Convivia™, Raptor's proprietary oral formulation of 4-methylpyrazole, in Taiwan.
Rutgers researchers studying COVID-19 have created a new way to deliver DNA molecules into skin cells, using a suction technique similar to the ancient healing practice of cupping.
› Verified 6 days ago
Entity Name | The Cardiovascular Group, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366498933 PECOS PAC ID: 2062305360 Enrollment ID: O20040202001017 |
News Archive
Scientists have engineered tissue grafts that, in pigs, regenerated both bone and cartilage in the temporomandibular joint (TMJ), a part of the jaw that can cause debilitating pain and disability when damaged.
Over the course of 2017, positive trends in insurance coverage and healthcare access from the Affordable Care Act reversed, particularly for low-income residents of states that did not expand Medicaid.
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Raptor Pharmaceutical Corp., announced that it has entered into an exclusive agreement with Uni Pharma Co., Ltd. to commercialize Convivia™, Raptor's proprietary oral formulation of 4-methylpyrazole, in Taiwan.
Rutgers researchers studying COVID-19 have created a new way to deliver DNA molecules into skin cells, using a suction technique similar to the ancient healing practice of cupping.
› Verified 6 days ago
Entity Name | Virginia Hospital Center Arlington Health System |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790785996 PECOS PAC ID: 8820065022 Enrollment ID: O20040916000413 |
News Archive
Scientists have engineered tissue grafts that, in pigs, regenerated both bone and cartilage in the temporomandibular joint (TMJ), a part of the jaw that can cause debilitating pain and disability when damaged.
Over the course of 2017, positive trends in insurance coverage and healthcare access from the Affordable Care Act reversed, particularly for low-income residents of states that did not expand Medicaid.
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Raptor Pharmaceutical Corp., announced that it has entered into an exclusive agreement with Uni Pharma Co., Ltd. to commercialize Convivia™, Raptor's proprietary oral formulation of 4-methylpyrazole, in Taiwan.
Rutgers researchers studying COVID-19 have created a new way to deliver DNA molecules into skin cells, using a suction technique similar to the ancient healing practice of cupping.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Michael P Notarianni, MD 2901 Telestar Ct., #300, Falls Church, VA 22042-1263 Ph: (703) 591-1688 | Michael P Notarianni, MD 1005 N Glebe Rd, #750, Arlington, VA 22201-5718 Ph: (703) 524-7202 |
News Archive
Scientists have engineered tissue grafts that, in pigs, regenerated both bone and cartilage in the temporomandibular joint (TMJ), a part of the jaw that can cause debilitating pain and disability when damaged.
Over the course of 2017, positive trends in insurance coverage and healthcare access from the Affordable Care Act reversed, particularly for low-income residents of states that did not expand Medicaid.
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Raptor Pharmaceutical Corp., announced that it has entered into an exclusive agreement with Uni Pharma Co., Ltd. to commercialize Convivia™, Raptor's proprietary oral formulation of 4-methylpyrazole, in Taiwan.
Rutgers researchers studying COVID-19 have created a new way to deliver DNA molecules into skin cells, using a suction technique similar to the ancient healing practice of cupping.
› Verified 6 days ago
Dr. Alvaro Andres Puig Rodriguez, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1625 N George Mason Dr Ste 425, Arlington, VA 22205 Phone: 703-717-4400 | |
Tiffany C Turner, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1625 N George Mason Dr Ste 345, Arlington, VA 22205 Phone: 703-717-4400 Fax: 703-717-4401 | |
Dr. Anne Ruggles Pariser, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2921 11th St S, Arlington, VA 22204 Phone: 703-979-1400 | |
Dr. Michael Andrew Cole, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1701 N George Mason Dr, Intensive Care Unit, Arlington, VA 22205 Phone: 571-244-8410 | |
Robert Paul Holman, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1635 N George Mason Dr, Suite 180, Arlington, VA 22205 Phone: 703-276-7798 Fax: 703-276-0433 | |
Dr. Irmindra S Rana, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 611 S Carlin Springs Rd, Suite 301, Arlington, VA 22204 Phone: 703-998-0480 Fax: 703-379-0449 | |
Dr. Ashok Chauhan, M.D., Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 611 S Carlin Springs Rd, Suite 511, Arlington, VA 22204 Phone: 703-379-4446 Fax: 703-379-0449 |